Journal of psychosocial oncology · 2024
Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Coupe Katie, Block Astrid, Mark Sueann, Cooper Bruce A, Paul Steven M, Dunn Laura B, Hammer Marilyn J, Conley Yvette P, Levine Jon D, Miaskowski Christine
Аннотация
PURPOSE: Identify subgroups of patients with distinct joint anxiety AND depression profiles and evaluate for differences in demographic and clinical characteristics, as well as stress, resilience, and coping.
DESIGN: Longitudinal study.
PARTICIPANTS: Patients (n = 1328) receiving chemotherapy.
METHODS: Measures of state anxiety and depression were done six times over two cycles of chemotherapy. All of the other measures were completed prior to second or third cycle of chemotherapy. Latent profile analysis was used to identify the distinct joint anxiety and depression profiles.
FINDINGS: Three classes were identified (i.e. Low Anxiety and Low Depression (57.5%); Moderate Anxiety and Moderate Depression (33.7%), High Anxiety and High Depression (8.8%)). For all of the stress measures, a dose response effect was seen among the profiles. Two worst profiles reported higher occurrence rates for a number of adverse childhood experiences.
IMPLICATIONS FOR PROVIDERS: Patients need referrals for stress reduction techniques and mental health and social services.
DESIGN: Longitudinal study.
PARTICIPANTS: Patients (n = 1328) receiving chemotherapy.
METHODS: Measures of state anxiety and depression were done six times over two cycles of chemotherapy. All of the other measures were completed prior to second or third cycle of chemotherapy. Latent profile analysis was used to identify the distinct joint anxiety and depression profiles.
FINDINGS: Three classes were identified (i.e. Low Anxiety and Low Depression (57.5%); Moderate Anxiety and Moderate Depression (33.7%), High Anxiety and High Depression (8.8%)). For all of the stress measures, a dose response effect was seen among the profiles. Two worst profiles reported higher occurrence rates for a number of adverse childhood experiences.
IMPLICATIONS FOR PROVIDERS: Patients need referrals for stress reduction techniques and mental health and social services.